COVID-19 UPDATE

BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

We are proud to be recognized on the Deloitte 2020 Technology Fast 500 list
BDSI
BDSI
INSPIRING SOLUTIONS FOR BETTER HEALTH
BDSI advances novel therapies designed to improve the lives of people living with serious and debilitating chronic conditions

Purpose

BioDelivery Sciences International (BDSI) is a rapidly growing specialty pharmaceutical company working to deliver innovative therapies for individuals living with serious and debilitating chronic conditions.

Learn more

Patients

BDSI subscribes to a patients-first philosophy. We are a dynamic team driven by the knowledge that the work we do can have a positive impact on patients, their caretakers, and loved ones.

Learn more

Products

BDSI offers a diverse portfolio of solutions for the treatment of serious and debilitating chronic conditions, including unique therapeutic innovations like a buccal film technology designed to help optimize drug delivery.

Learn more

Recent BDSI News

February 17, 2021

RALEIGH, N.C. , Feb. 17, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its fourth quarter and full

Read more
February 11, 2021

Brings Track Record of Success to Expanded Role RALEIGH, N.C. , Feb. 11, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic conditions, promoted its Chief Financial Officer,

Read more
January 15, 2021

Oral Presentation of Data from Phase I Safety Study & Secondary Respiratory Outcomes Comparing BELBUCA ® to Oxycodone on January 16 from 1:10pm – 2:10pm CT RALEIGH, N.C. , Jan. 15, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a rapidly growing specialty

Read more
More news

Upcoming Events

BDSI Fourth Quarter 2020 Financial Results Call and Webcast March 10, 2021 8:30 AM EST

Stay Connected

Stay up to date on the latest news

Get started now
February 26, 2021BDSI $4.2/ - -4.76%
Data provided by Nasdaq. Minimum 15 minutes delayed.